Furthermore, while CD103+ and CD103- CD8+ T cells are present in endometrial tumors, the majority of cytotoxic activity is due to non-resident CD103- CD8+ T cells which account for approximately 40% of the CD8+ T cells in the tumor. The gene discussed is CD8A; the disease is endometrium neoplasm.